Jazz Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.About JAZZ
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.
JAZZ Key Statistics
Stock Snapshot
The current Jazz Pharmaceuticals(JAZZ) stock price is $234.66, with a market capitalization of 15.06B. The stock trades at a price-to-earnings (P/E) ratio of 77.93.
Jazz Pharmaceuticals(JAZZ) stock opened on 2026-11-05 at $233.23. The price climbed to — and dipped to —.
The Jazz Pharmaceuticals(JAZZ)'s current trading volume is 0, compared to an average daily volume of 934.9K.
During the past year, Jazz Pharmaceuticals(JAZZ) stock moved between $128.80 at its lowest and $266.38 at its peak.
During the past year, Jazz Pharmaceuticals(JAZZ) stock moved between $128.80 at its lowest and $266.38 at its peak.
JAZZ News
Jazz Pharmaceuticals (JAZZ) is back in focus after record third quarter revenue, a higher 2026 sales outlook, and fresh oncology data around Ziihera coincided w...
Jazz Pharmaceuticals (JAZZ) announced an update on their ongoing clinical study. Study Overview: Jazz Pharmaceuticals is evaluating JZP269 in a Phase 1 study o...
Jazz Pharmaceuticals came into this Q3 2026 earnings print with a bruised 90 day share performance and a rich P/E, yet the stock ripped 7.1% higher to about US$...
Analyst ratings
88%
of 24 ratingsMore JAZZ News
Jazz Pharmaceuticals (NasdaqGS:JAZZ) reported record quarterly revenue, setting a new high for the business in its latest results. The company rapidly launched...
Jazz Pharmaceuticals (JAZZ) announced an update on their ongoing clinical study. Study Overview: Jazz Pharmaceuticals’ NCT05772429 study, titled “Long-term Fol...
Jazz Pharmaceuticals reported updated Phase 3 HERIZON-GEA-01 data at ESMO 2026 showing Ziihera based regimens delivered longer median overall survival and reduc...
US inflation remains above the Federal Reserve's 2% target and higher gas prices are squeezing household budgets. That pressure often pushes investors to look f...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.